<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Several secondary causes are implicated in the etiology of idiopathic intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="8887">Rofecoxib</z:chebi> is a selective cyclo-oxygenase (COX)-2 inhibitor, now being increasingly used in place of nonselective <z:chebi fb="2" ids="35475">nonsteroidal anti-inflammatory drugs</z:chebi> (<z:chebi fb="1" ids="35475">NSAIDs</z:chebi>) </plain></SENT>
<SENT sid="2" pm="."><plain>We report a case of intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> in a 69-year-old man 3 weeks after the commencement of <z:chebi fb="0" ids="8887">rofecoxib</z:chebi> therapy with reversal of clinical findings on <z:e sem="disease" ids="C0152128" disease_type="Disease or Syndrome" abbrv="">drug withdrawal</z:e> </plain></SENT>
</text></document>